U.S. Pharma Stock News

NYSE:OSK
NYSE:OSKMachinery

Is Oshkosh (OSK) Balancing Board Power and Geopolitical Risk or Creating New Uncertainties?

On March 26, 2026, Oshkosh Corporation filed a definitive proxy statement urging shareholders to vote against a proposal that would require directors failing to win majority support in uncontested elections to leave the board within nine months, ahead of its May 5, 2026 annual meeting. This governance dispute coincides with improved geopolitical sentiment around tensions involving Iran, offering a fresh angle on Oshkosh’s risk profile and board accountability. Next, we’ll examine how the...
NYSE:CSR
NYSE:CSRResidential REITs

Is Rising Activist Ownership And Board Turnover Altering The Investment Case For Centerspace (CSR)?

Recently, activist investor Land & Buildings raised its stake in Centerspace REIT to 9.19%, coinciding with Board Member Emily Nagle Green’s retirement and the declaration of a quarterly dividend. Taken together, the larger activist presence and board change may point to upcoming discussions around Centerspace’s capital allocation and portfolio direction. With Land & Buildings now owning over 9% of Centerspace, we’ll examine how this increased activist involvement could reshape its...
NYSE:ES
NYSE:ESElectric Utilities

How Eversource’s Governance Clash And FERC Return Dispute At Eversource Energy (ES) Has Changed Its Investment Story

In March 2026, Eversource Energy filed its definitive proxy statement urging shareholders to vote against a proposal to permanently separate the Chairman and CEO roles at the upcoming May 6 annual meeting. This governance dispute emerges as Eversource also challenges a Federal Energy Regulatory Commission ruling that lowers allowed returns on its New England transmission assets, adding a layer of regulatory tension to the company’s outlook. We’ll now assess how Eversource’s pushback against...
NYSE:FUBO
NYSE:FUBOInteractive Media and Services

FuboTV Reverse Stock Split Reshapes Share Structure And Dividend Outlook

FuboTV (NYSE:FUBO) approved a reverse stock split and amended its bylaws to reflect the change. The reverse split has already been implemented, consolidating existing shares into a smaller number. These actions adjust the company’s share structure and may influence its exchange listing status and future financing options. FuboTV operates a live TV streaming platform focused on sports, news, and entertainment, positioning itself as an alternative to traditional cable bundles. The reverse...
NYSE:UVV
NYSE:UVVTobacco

Should Universal’s Revenue Miss and New CFO Hire Reshape the Core Investment Case for UVV?

Universal Corporation recently reported past third-quarter revenue of US$861.3 million, below the prior year’s level, while also announcing the appointment of Anubhav Mittal as Senior Vice President and Chief Financial Officer, effective February 17, 2026. Despite a tobacco oversupply, management emphasized firm customer demand and smooth shipments in the tobacco segment, suggesting operational resilience amid challenging market conditions. With Universal’s revenue miss and incoming CFO now...
NYSE:SEE
NYSE:SEEPackaging

Assessing Sealed Air (SEE) Valuation After A Strong 1 Year Shareholder Return

Why Sealed Air Is On Investors’ Radar Sealed Air (SEE) has been drawing attention after recent share price moves, prompting investors to take a fresh look at its packaging business, current valuation signals, and how its returns have varied across different time frames. See our latest analysis for Sealed Air. The share price at US$42.08 has been relatively steady in the short term, while the 1 year total shareholder return of 76.16% contrasts with flat to slightly negative total shareholder...
NasdaqGS:PAGP
NasdaqGS:PAGPOil and Gas

Is Plains GP’s US$938.9 Million Shelf Registration Altering The Investment Case For PAGP?

In late March 2026, Plains GP Holdings, L.P. filed shelf registrations for its Class A common shares, covering up to US$938.9 million in potential future issuances. This move gives the company additional flexibility to tap equity markets over time, a step that can meaningfully influence how investors think about future capital raising and ownership dilution. Next, we'll examine how this new US$938.9 million Class A share shelf registration could influence Plains GP Holdings' investment...
NYSE:WEC
NYSE:WECIntegrated Utilities

How Investors May Respond To WEC Energy Group (WEC) Extending Oak Creek And Raising Multi‑Year Rates

WEC Energy Group’s Wisconsin utilities recently filed multi-year rate requests and delayed retirement of Oak Creek Power Plant units 7 and 8 through 2027 to support grid reliability and fund infrastructure and clean energy investments, while also advancing governance changes by proposing to remove supermajority voting requirements from its Articles of Incorporation and Bylaws. The company also received Federal Energy Regulatory Commission acknowledgement that its Sandstone Rapids...
NYSE:HLX
NYSE:HLXEnergy Services

Is Strong Q4 Execution And New UK P&A Contract Altering The Investment Case For Helix (HLX)?

In recent days, Helix Energy Solutions Group reported fourth-quarter results with revenue slightly lower year on year but materially ahead of analyst expectations on EPS and EBITDA, while also securing a multi-year well plug and abandonment program in the UK North Sea. At the same time, rising crude prices amid heightened U.S.–Iran tensions have drawn attention to how geopolitical risk can influence demand for Helix’s offshore services and earnings potential. We’ll now examine how Helix’s...
NasdaqGM:BCAX
NasdaqGM:BCAXBiotechs

A Look At Bicara Therapeutics (BCAX) Valuation After Analyst Upgrades And Clinical Progress News

Recent gains in Bicara Therapeutics (BCAX) stock have come alongside a series of fresh analyst updates, earnings results and clinical progress headlines that have sharpened attention on the company’s development pipeline. See our latest analysis for Bicara Therapeutics. The recent analyst upgrades and clinical updates have come alongside a clear build in momentum, with a 30 day share price return of 16.24% and a 1 year total shareholder return of 103.12% at a latest share price of $21.47. If...
NasdaqGS:UPWK
NasdaqGS:UPWKProfessional Services

Upwork Expands AI Platform As Valuation Gap Draws Investor Attention

Upwork (NasdaqGS:UPWK) is rolling out new AI driven features on its freelance platform, including its assistant Uma and expanded workforce management tools. The company is extending these capabilities across its marketplace to support both businesses and freelancers who rely on remote and project based work. The updates are part of an ongoing effort to integrate AI into talent discovery, project scoping, and ongoing engagement on the platform. For investors tracking online talent platforms,...
NYSE:WOR
NYSE:WORMachinery

How Investors May Respond To Worthington Enterprises (WOR) Earnings Growth And Ongoing Shareholder Returns

In March 2026, Worthington Enterprises, Inc. reported higher year-over-year third-quarter and nine-month sales and net income, continued its share repurchases, and its Board declared a US$0.19 per-share quarterly dividend payable on June 29, 2026. Together, the earnings growth, ongoing buybacks that have retired more than two-fifths of shares since 2014, and the uninterrupted dividend record since 1968 highlight the company’s long-running focus on returning cash to shareholders. Next, we’ll...
NasdaqGM:RCMT
NasdaqGM:RCMTProfessional Services

RCM Technologies (RCMT) EPS Growth And 5.1% Margin Reinforce Bullish Narratives

RCM Technologies (RCMT) has wrapped up FY 2025 with fourth quarter revenue of US$86.5 million, basic EPS of US$0.80 and net income of US$6.1 million. The trailing twelve months show revenue of US$319.4 million, EPS of US$2.19 and net income of US$16.3 million, with earnings growth of 22.4% over the past year. Over recent periods the company has seen revenue move from US$278.4 million to US$319.4 million on a trailing basis, alongside EPS shifting from US$1.72 to US$2.19. This ties into a net...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

Do Ongoing DCCR Lawsuits Reframe Soleno Therapeutics’ (SLNO) Risk Profile More Than Its Drug Potential?

In recent months, Soleno Therapeutics has faced multiple securities class action lawsuits alleging that the company and certain executives failed to disclose material safety concerns and data integrity issues tied to the Phase 3 program for its Prader‑Willi syndrome drug DCCR, marketed as VYKAT XR. These legal challenges, centered on claims of undisclosed risks such as fluid retention, diabetes‑related markers, and high discontinuation rates, have intensified scrutiny of VYKAT XR’s clinical...
NYSE:AGO
NYSE:AGOInsurance

Did Francisco Borges’ US$9.9 Million Share Sale Just Reframe Assured Guaranty’s (AGO) Risk Appetite?

In recent days, Assured Guaranty director Francisco Borges sold 123,750 shares of the company, a transaction worth nearly US$9.93 million, marking a large reduction in his personal stake. This insider sale comes as Assured Guaranty balances strong profitability and a solid balance sheet with pressures from lower-yield AA business and its Assured Life Re annuity reinsurance expansion. We’ll now examine how Borges’ sizable insider sale could influence Assured Guaranty’s investment narrative,...
NasdaqCM:NNE
NasdaqCM:NNEElectrical

If You Believe In The Nuclear Renaissance Then These Three Stocks Define The Next Power Cycle

AI data centers, stubborn energy costs, and heightened geopolitical risk are all pushing reliable, carbon free power to the forefront of investment thinking. Nuclear sits at the center of that discussion, with governments, utilities, and large corporates all searching for 24/7 electricity that does not depend on weather or imported fossil fuels. Our Nuclear Renaissance screener is built to help you focus on listed companies most closely aligned with this long term trend. In this article, you...
NasdaqGS:MMED
NasdaqGS:MMEDMedical Equipment

A Look At Minimed Group (MMED) Valuation After Recent Share Price Weakness

Event context and recent price performance Minimed Group (MMED) has been in focus after recent share price weakness, with the stock down 3.2% over the past week and 24.2% year to date. This has prompted fresh attention on its fundamentals. The Northridge based diabetes technology company reports annual revenue of US$2,886 and a net loss of US$211. This places its current valuation of about US$3.9b under closer scrutiny among investors. See our latest analysis for Minimed Group. With the...
NYSE:GPN
NYSE:GPNDiversified Financial

Global Payments Lands IRS Role Raising Questions On Value And Growth

Global Payments' Link2Gov unit has been selected by the IRS as a preferred digital payments provider for the 2026 tax season. The mandate covers digital tax payments, highlighting Link2Gov's role in supporting federal e-payment capabilities. This selection places NYSE:GPN directly in the middle of U.S. government efforts to modernize tax collection systems. Global Payments, through its Link2Gov unit, is focused on digital payment processing across government and enterprise clients. Being...
NYSE:TPB
NYSE:TPBTobacco

Is It Time To Reassess Turning Point Brands (TPB) After The Recent Share Price Pullback

For investors wondering if Turning Point Brands at around US$72.16 is still offering value or if the easy gains are behind it, this article focuses squarely on what the current price might be implying. The stock has pulled back sharply in the short term, with a 15.5% decline over the last 7 days and a 21.9% decline over the last 30 days, even though the 1 year return sits at 32.8% and the 3 year return is 254.2%. Recent market attention has centered on how this performance, including a year...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

How Investors Are Reacting To Golar LNG (GLNG) Strategic Review And New Omnibus Shelf Registration

In late March 2026, Golar LNG Limited filed an omnibus shelf registration covering a broad range of securities and separately began a formal review of options such as a sale, merger, asset divestitures, or corporate structure changes to accelerate its Floating Liquefied Natural Gas (FLNG) growth plans. This combination of financing flexibility and a wide-ranging review of potential transactions highlights how Golar is reassessing how best to monetize its FLNG platform, long-term contract...
NYSE:BKSY
NYSE:BKSYProfessional Services

BlackSky Wins US$99 Million Contract And Draws Fresh Valuation Questions

BlackSky Technology (NYSE:BKSY) received a sole source, multi year US$99 million IDIQ contract from the U.S. government. The award comes from the Air Force Research Laboratory and targets advanced optical payload and next generation space intelligence capabilities. The contract focuses on large aperture optical systems and AI enabled space data tools that differ from BlackSky's existing Gen 2 and Gen 3 offerings. For readers tracking NYSE:BKSY, this contract sits at the center of the...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Royalty Pharma Leans Into R&D And AI To Shape Future Royalties

Royalty Pharma (NasdaqGS:RPRX) has entered into a new R&D co-funding agreement with Johnson & Johnson to develop a novel autoimmune therapy. The company has also appointed a Head of Artificial Intelligence to expand the use of advanced analytics and data science across its operations. These announcements mark a shift toward greater involvement in drug development and data driven decision making. Royalty Pharma, known primarily for acquiring biopharma royalties, typically gives investors...
NYSE:CTRA
NYSE:CTRAOil and Gas

Coterra Devon Merger Cleared As Valuation Gap Draws Investor Focus

Regulators allowed the Hart Scott Rodino antitrust waiting period for Coterra Energy's merger with Devon Energy to expire, clearing a key hurdle. This approval means Coterra Energy (NYSE:CTRA) can move toward closing, with the company expected to become a wholly owned subsidiary of Devon. The companies currently anticipate closing the transaction in Q2 2026, subject to remaining customary conditions. Coterra Energy focuses on oil and gas exploration and production, an area where scale, cost...